Medline Inc. is 35.6x more valuable than AtriCure, Inc. by market capitalization ($49.12 B vs $1.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATRC | MDLN |
|---|---|---|
| Market cap | $1.38 B | $49.12 B |
| US-listed rank | #2402 | #322 |
| Revenue (latest FY) | $534.53M | $28.43B |
| Net income (latest FY) | -$11.45M | $1.16T |
| Net margin | -2.1% | 4069.4% |
| P/E (trailing FY) | - | 0.0 |
| SEC filings | 1,531 | 103 |
Medline Inc. is 35.6x more valuable than AtriCure, Inc. by market capitalization ($49.12 B vs $1.38 B).
In their latest fiscal years, AtriCure, Inc. reported $534.53M in revenue while Medline Inc. reported $28.43B.
Full pages: AtriCure, Inc. and Medline Inc., or browse the full rankings.